Home LiteratureArticle Details
PMID: 25560537 Published · ppublish English Journal Article

Genetic testing and FDA regulation: overregulation threatens the emergence of genomic medicine.

JAMA ·Vol. 313 ·No. 7 ·2015-02-17 ·Pages 669-70

Evans JP, Watson MS

Abstract

暂无摘要

MeSH Terms
Genetic Testing/legislation & jurisprudence,standards Genomics Government Regulation Humans Precision Medicine United States United States Food and Drug Administration
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Evans James P
Departments of Genetics and Medicine, University of North Carolina at Chapel Hill.
Watson Michael S
American College of Medical Genetics and Genomics, Bethesda, Maryland3ACMG Foundation for Genetic and Genomic Medicine, Bethesda, Maryland.
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
1538-3598
DOI
10.1001/jama.2014.18145
Published
2015-02-17
Pages
669-70
Language
English
Region
United States
NLM ID
7501160
Subset
IM
External Links
PubMed source DOI: 10.1001/jama.2014.18145 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2